Breakthrough Drug: A Last-Resort Against Superbugs
A breakthrough antibiotic that outsmarts deadly superbugs using a "Trojan horse" strategy is giving hope to American hospitals battling infections that have killed thousands.
Story...
Your Coffee May Hide a Silent Toxin
Ochratoxin A, a pervasive mycotoxin in our food supply, may be quietly impacting our health more than we realize.
Story Overview
Ochratoxin A (OTA) is...
Fertility Treatments’ Hidden Heart Disease Cost.
Women pursuing fertility treatments may be unknowingly trading their reproductive dreams for elevated cardiovascular risks that could haunt them for decades.
Story Overview
Assisted reproductive...
Leukemia Drug Resistance May Be Finally Broken
A humble plant compound used in traditional medicine has just demonstrated the power to outsmart one of medicine's most ruthless killers while making chemotherapy...
Unlock Pumpkin’s Amazing Health Benefits
Pumpkin, long hailed as a seasonal delight, may actually be one of the most potent health allies when consumed regularly.
Story Snapshot
Pumpkin is a...
Walking: Ancient Wisdom for Modern Grief
A global art project transformed grief from an isolating burden into a collective healing ritual through synchronized walking meditations across four continents.
Story Highlights
Untold...
Breast Cancer Breakthrough, Price Shock: Get Details
A powerful new breast cancer drug is extending women’s lives, even as Big Pharma pricing still threatens family budgets.
Story Snapshot
A large phase 3...
Hepatitis B: Reversing 30 Years of Progress
A federal vaccine advisory panel has voted to no longer recommend hepatitis B vaccinations for newborns.
Story Snapshot
Advisory panel votes against recommending birth dose...
Infant Tongue-Tie: A Controversial Diagnosis
A new medical trend threatens to undermine informed parenting by promoting unnecessary surgeries for infants, raising concerns among healthcare professionals.
Story Snapshot
Tongue-tie procedures for...
Rethinking Cancer Therapy for Patients Over 80
Older patients with diffuse large B-cell lymphoma (DLBCL) are experiencing promising outcomes with the Pola-R-CHP therapy, challenging previous norms in oncology treatment.
Story Overview
Pola-R-CHP...
